• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Introduction to 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride (CAS No. 860363-17-3)

1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride (CAS No. 860363-17-3) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as HCl salt of 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid, has garnered attention due to its unique structural properties and potential therapeutic effects. In this article, we will delve into the chemical structure, synthesis methods, biological activities, and recent research advancements associated with this compound.

The chemical structure of 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride is characterized by a pyrrolopyridine core with a carboxylic acid group and a hydrochloride salt. The pyrrolopyridine scaffold is a privileged structure in medicinal chemistry, often found in bioactive molecules with diverse pharmacological activities. The presence of the carboxylic acid group and the hydrochloride salt form enhances the compound's solubility and stability, making it suitable for various pharmaceutical applications.

The synthesis of 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride has been extensively studied. One common approach involves the condensation of an appropriate pyrrole derivative with a pyridine carboxylic acid or its ester, followed by acidic workup to form the hydrochloride salt. Recent advancements in synthetic methodologies have focused on improving the efficiency and scalability of these reactions, utilizing green chemistry principles to minimize environmental impact.

In terms of biological activities, 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride has shown promising results in various preclinical studies. Research has demonstrated its potential as an inhibitor of specific enzymes and receptors involved in disease pathways. For instance, studies have explored its activity as an inhibitor of kinases, which are key regulators of cellular signaling pathways implicated in cancer and inflammatory diseases. Additionally, the compound has been investigated for its anti-inflammatory properties and its ability to modulate immune responses.

One notable area of research involves the use of 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride in the treatment of neurodegenerative diseases. Preclinical studies have suggested that this compound may have neuroprotective effects by reducing oxidative stress and inhibiting neuroinflammation. These findings have opened new avenues for the development of novel therapeutic strategies targeting neurological disorders such as Alzheimer's disease and Parkinson's disease.

Clinical trials are currently underway to evaluate the safety and efficacy of 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride in various therapeutic settings. Early results from phase I trials have shown that the compound is well-tolerated at therapeutic doses, with minimal adverse effects. These promising outcomes have paved the way for further clinical investigations to explore its potential as a treatment for a range of diseases.

Beyond its direct therapeutic applications, 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride has also been used as a building block in the synthesis of more complex molecules with enhanced biological activities. Its structural versatility allows for the introduction of various functional groups through chemical modifications, enabling researchers to fine-tune the pharmacological properties of derived compounds.

In conclusion, 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid hydrochloride (CAS No. 860363-17-3) is a promising compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure, coupled with its diverse biological activities and favorable pharmacological properties, makes it an attractive candidate for further development as a therapeutic agent. Ongoing research continues to uncover new applications and optimize its use in various medical contexts.

• 952800-39-4(Methyl 1H-pyrrolo[3,2-B]pyridine-3-carboxylate)
• 112766-32-2(1H-Pyrrolo[3,2-b]pyridine-6-carboxylic acid)
• 1190315-00-4(6-(Methoxycarbonyl)-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid)
• 1227270-42-9(6-Phenyl-3-(4-azaindole)carboxylic Acid)
• 1190319-18-6(1H-Pyrrolo[3,2-b]pyridine-7-carboxylic acid)
• 1190315-88-8(6-Cyano-4-azaindole-3-carboxylic Acid)
• 860496-20-4(1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid)
• 369652-76-6(pyrazino[2,3-a]phenazine-11-carboxylic acid)
• 90418-64-7(1,5-Naphthyridine-3-carboxylic acid)
• 79426-14-5(1,5-Naphthyridine-4-carboxylic acid)